Approved Ligands

InformationUmbralisib (TGR-1202, Rp-5264), a novel, next generationPI3Kδinhibitor, inhibits PI3Kδ activity in enzyme and cell based assays withIC50andEC50values of 22.2 &amp: 24.3 nM, respectively.TargetsPI3Kδ (Cell-free assay) 22.2 nMIn vitroThe

InformationUmbralisib (TGR-1202, Rp-5264), a novel, next generationPI3Kδinhibitor, inhibits PI3Kδ activity in enzyme and cell based assays withIC50andEC50values of 22.2 &amp: 24.3 nM, respectively.TargetsPI3Kδ (Cell-free assay) 22.2 nMIn vitroThe

InformationUmbralisib (TGR-1202, Rp-5264), a novel, next generationPI3Kδinhibitor, inhibits PI3Kδ activity in enzyme and cell based assays withIC50andEC50values of 22.2 &amp: 24.3 nM, respectively.TargetsPI3Kδ (Cell-free assay) 22.2 nMIn vitroThe

Upadacitinib.

Upadacitinib.

Upadacitinib.

Upadacitinib.

Vandetanib is an antagonist of VEGFR (Flk and Flk) and EGFR families. Specifically inhibits kinase activity of Flk-1. Vandetanib is an inhibitor of Flt-4.An antagonist of VEGFR (Flk and Flk) and EGFR families.

Vandetanib is an antagonist of VEGFR (Flk and Flk) and EGFR families. Specifically inhibits kinase activity of Flk-1. Vandetanib is an inhibitor of Flt-4.An antagonist of VEGFR (Flk and Flk) and EGFR families.

Vandetanib is an antagonist of VEGFR (Flk and Flk) and EGFR families. Specifically inhibits kinase activity of Flk-1. Vandetanib is an inhibitor of Flt-4.An antagonist of VEGFR (Flk and Flk) and EGFR families.

Vardenafil hydrochloride Trihydrate.

Vardenafil hydrochloride Trihydrate.